SOURCE: digiMedical Solutions, Inc.

February 28, 2008 10:19 ET

digiMedical Solutions, Inc. Announces Pharmaceutical Inventory Agreement With Crossroads Financial to Increase Working Capital and Support $10 Million Revenue Goal

Recent CEO Interview Now Available on

COLLEYVILLE, TX--(Marketwire - February 28, 2008) - digiMedical Solutions, Inc. (PINKSHEETS: DGMS) today announced entering into an agreement with Crossroads Financial to increase the company's working capital by being able to borrow against the company's pharmaceutical inventory. Currently, digiMedical's pharmacy chain has hundreds of thousands of dollars in inventory reserves. This inventory can now be leveraged to add working capital to increase company sales. Under this agreement, digiMedical will receive 50% of the value of its current inventory. For example, a $1,000,000 inventory means $500,000 for reinvestment.

David Lee, CEO of digiMedical, stated, "This agreement reflects the company's maturity and is a tool to help us to continue to grow toward our anticipated $10 million in 2008 revenue and beyond."

digiMedical Solutions, a Microsoft Partner, with operations in Texas and Florida, has built its own suite of proprietary software to handle prescriptions digitally from the physician's office to the pharmacy, securely and in compliance with all DEA and HIPAA requirements. The suite of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and now digiAccounting and the Company owns and operates five pharmacies throughout Texas and Florida.

CEO Interview on

Earlier this week, Mr. Lee updated the investment community in an interview with The interview covered the company's business plan for growth to an anticipated $10 million in profitable revenue in 2008, market opportunity, recent achievements and key management. The Company currently has annualized revenue of approximately $6 million. digiMedical also anticipates an analyst report reviewing the Company's current and future operations expected to be released soon. To listen to the interview, go to

To be added to digiMedical's corporate e-mail list for shareholders and interested investors, please send an e-mail to

About Crossroads Financial, LLC (

Crossroads provides a combination of products unique to the finance industry. By providing both Inventory and Purchase Order funding we can offer a one stop shop for clients to maximize their growth and working capital availability.

About digiMedical Solutions, Inc.™ (

digiMedical Solutions, Inc.™ currently owns and operates five pharmacies throughout Texas and Florida and is a Microsoft Independent Software Vendor (ISV). digiMedical is both a pharmacy and medical technology company focused on developing next generation, digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that closely align the doctor, pharmacist and patient. digiMedical Solutions™ unique business model connects physicians, patients and pharmacies with next generation medical technologies.

The company's continued growth will come from three channels: direct marketing of the company's wireless based d-prescription technology to physicians, acquisition of independent pharmacy chains and the sale of select territories to "market partners" licensed to exploit the digiMedical Solutions™ model.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company's business and results of operations.

Contact Information